Literature DB >> 9430380

Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.

X Fang1, T L Kaduce, N L Weintraub, A A Spector.   

Abstract

Arachidonic acid is converted to epoxyeicosatrienoic acids (EETs) by cytochrome P450 monooxygenases. EETs produce arterial vasodilatation, and recent evidence suggests that they are endothelium-derived hyperpolarizing factors. In porcine coronary arteries contracted with a thromboxane mimetic agent, we find that relaxation is rapidly initiated by exposure to 14,15-EET. The relaxation slowly increases in magnitude, resulting in a response which is sustained for more than 10 min. Cultured porcine aortic smooth muscle cells rapidly take up [3H]14,15-EET. After 3 min, radioactivity is present in neutral lipids, phosphatidylcholine, and phosphatidylinositol. The cells also convert 14,15-EET to 14,15-dihydroxyeicosatrienoic acid (14,15-DHET), and some DHET is detected in the medium after only 1 min of incubation. Like 14,15-EET, 14,15-DHET produces relaxation of the contracted coronary artery rings. These findings suggest that the incorporation into phospholipids and conversion to 14,15-DHET can occur at a rate that is fast enough to modulate the vasorelaxation produced by 14,15-EET.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9430380     DOI: 10.1016/s0952-3278(97)90412-9

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  12 in total

Review 1.  Use of metabolomic profiling in the study of arachidonic acid metabolism in cardiovascular disease.

Authors:  Ning Li; Jun-Yan Liu; Hong Qiu; Todd R Harris; Padmini Sirish; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Congest Heart Fail       Date:  2011-01-27

2.  Cardioprotective effect of a dual acting epoxyeicosatrienoic acid analogue towards ischaemia reperfusion injury.

Authors:  S N Batchu; S B Lee; R S Qadhi; K R Chaudhary; H El-Sikhry; R Kodela; J R Falck; J M Seubert
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

3.  Constitutive and inducible expression of cytochrome P450IA1 and P450IB1 in human vascular endothelial and smooth muscle cells.

Authors:  W Zhao; A R Parrish; K S Ramos
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

4.  Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Authors:  Benjamin B Davis; David A Thompson; Laura L Howard; Christophe Morisseau; Bruce D Hammock; Robert H Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

5.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

Review 6.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

7.  Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

Authors:  Brandon T Larsen; Hiroto Miura; Ossama A Hatoum; William B Campbell; Bruce D Hammock; Darryl C Zeldin; John R Falck; David D Gutterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-28       Impact factor: 4.733

8.  Plasma oxylipin profiling identifies polyunsaturated vicinal diols as responsive to arachidonic acid and docosahexaenoic acid intake in growing piglets.

Authors:  Maaike J Bruins; Adrie D Dane; Katrin Strassburg; Rob J Vreeken; John W Newman; Norman Salem; Cynthia Tyburczy; J Thomas Brenna
Journal:  J Lipid Res       Date:  2013-03-29       Impact factor: 5.922

Review 9.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 10.  Epoxygenase metabolites. Epithelial and vascular actions.

Authors:  J D Imig
Journal:  Mol Biotechnol       Date:  2000-11       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.